Financials

News Ideas Technicals

300254 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SHANXI CY PHARMACE operating, investing, and financing activities

300254 free cash flow for Q1 24 is -11.16 M CNY. For 2023, 300254 free cash flow was 3.9 M CNY and operating cash flow was 37.81 M CNY.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CNY

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—